BioArctic AB (publ) (BIOA-B) — Capital Reinvestment Ratio
Latest as of June 2025:
1.00x
BioArctic AB (publ) (BIOA-B) has a Capital Reinvestment Ratio of 1.00x as of June 2025, meaning it reinvests 1% of its operating cash flow (Skr1.15 Billion) in capital expenditures (Skr1.15 Billion). See BIOA-B free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
1.00x
Capex / Operating Cash Flow
Operating Cash Flow
Skr1.15 Billion
SEK
Capital Expenditures
Skr1.15 Billion
SEK
Data as of
Jun 2025
Most recent filing
BioArctic AB (publ) Capital Reinvestment Ratio (2016–2023)
This chart tracks BioArctic AB (publ)'s Capital Reinvestment Ratio across 3 annual periods.
Annual Capital Reinvestment Ratio for BioArctic AB (publ) (2016–2023)
Year-by-year Capital Reinvestment Ratio for BioArctic AB (publ) from 2016 to 2023. For live market cap and broader valuation context, see BioArctic AB (publ) (BIOA-B) total market value.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.02x | Skr309.69 Million | Skr7.44 Million | ▲ +141.0% |
| 2019 | 0.01x | Skr327.17 Million | Skr3.26 Million | ▲ +126.9% |
| 2016 | 0.00x | Skr675.13 Million | Skr2.97 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow